
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES88
Finally, the review did not report significant differences between different BP lowering regimens
(i.e. head-to-head comparisons) in terms of stroke, CHD, heart failure in patients with diabetes.
The exception being CCBs, which were associated with a higher risk of heart failure when they
were compared with diuretics or beta-blockers,234 (see tables 12.6.112.6.3 for outcomes). In the
same way, no differences were seen in the head-to-head comparisons for total major CV events,
CV deaths, and total mortality in patients with diabetes.

[@Bakris_2003]

[@Sengul_2006]

